CRTC1 has been suggested to act as a critical role in several neurodegenerative diseases, such as Alzheimer’s disease [29–31], and Huntington’s disease [32, 33]. This evidence concerns the gene CRTC1 and early-onset autosomal dominant Alzheimer disease.